The global plant-based vaccines market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021, growing at a CAGR of 12.9 % from 2021 to 2028.
Increasing research & development (R & R&D) activities and the growing prevalence of infectious diseases are fueling the market's growth. However, the potential risk of contamination and environmental risks of manufacturing the vaccines are expected to restrain the market growth during the forecast period.
Plant-based vaccines can be made in a cost-effective way and produced on a large scale. Patients can readily accept these vaccines. Moreover, these vaccines are stable for long-term antigen storage. They also help to reduce the economic burden of infectious disease globally. Various plants, such as potato, rice, maize, tomato, carrot, tobacco, soybean, and peanut, have been used to develop plant-derived vaccines. The choice of the plant depends on the route of administration of the vaccine. Various clinical trials are being conducted to develop plant-based vaccines in therapeutic indications such as influenza, flu, and Ebola virus.
Infectious disorders or diseases are caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungus, and they can be transmitted from one person to another either directly or indirectly. These diseases can be divided into three categories - diseases that cause high levels of mortality, diseases that inflict a large load of disability on populations, and diseases that - due to their rapid and unexpected spread - can have serious global consequences. Many of the significant health factors and infectious disease causes are beyond the health sector's direct control.
The rising prevalence of infectious diseases such as COVID-19, influenza, the common cold, tuberculosis (TB), hepatitis A and B is expected to flourish the demand for plant-based vaccines during the forecast period. On December 31, 2019, a COVID-19 case was first detected in Wuhan, China. On March 11, 2020, the World Health Organization proclaimed COVID-19 a pandemic. COVID-19's rapid proliferation is posing a challenge to the healthcare systems around the world. Hospitals and intensive care units (ICUs) in many nations are overburdened or on the verge of collapsing. As a result, the most efficient use of healthcare resources is required. With limited access to breathing equipment, skilled critical care employees, or protected patient monitoring systems, healthcare providers are compelled to treat extremely ill patients. The endeavor to keep COVID-19 patients from deteriorating and being admitted to the ICU is enormous. To slow the spread of the SARS-CoV-2 virus and prevent future outbreaks, the need for new diagnostics, treatments, and vaccinations is high.
Malaria is the most common tropical human disease caused by protozoan parasites, with an increasing incidence and mortality rate. Furthermore, there are currently no licensed vaccinations for this disease, fueling the need to develop an effective and reliable anti-malaria vaccine that can protect humans from various parasitic infection stages containing various malaria antigens. For example, according to the WHO figures from July 2018, there were 216 million malaria cases worldwide in 2016, with 445,000 deaths reported. The worldwide plant-based vaccine market is expected to rise due to rising influenza incidence rates. According to the Centers for Disease Control and Prevention (CDC), in the US, influenza caused 49,000,000 symptomatic illnesses and 79,000 fatalities in 2017-2018. Hence, the rising number of infectious diseases worldwide is anticipated to boost the growth of the plant-based vaccines market during the forecast period.
Based on application, the global plant-based vaccines market is segmented into influenza, zika virus, Ebola virus, poultry disease, COVID-19, and others. The influenza segment held the largest share of the market. However, the COVID-19 segment is anticipated to register the highest CAGR of 13.8% in the market during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the plant-based vaccines market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the National Center for Biotechnology Information (NCBI).Reasons to Buy
Increasing research & development (R & R&D) activities and the growing prevalence of infectious diseases are fueling the market's growth. However, the potential risk of contamination and environmental risks of manufacturing the vaccines are expected to restrain the market growth during the forecast period.
Plant-based vaccines can be made in a cost-effective way and produced on a large scale. Patients can readily accept these vaccines. Moreover, these vaccines are stable for long-term antigen storage. They also help to reduce the economic burden of infectious disease globally. Various plants, such as potato, rice, maize, tomato, carrot, tobacco, soybean, and peanut, have been used to develop plant-derived vaccines. The choice of the plant depends on the route of administration of the vaccine. Various clinical trials are being conducted to develop plant-based vaccines in therapeutic indications such as influenza, flu, and Ebola virus.
Infectious disorders or diseases are caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungus, and they can be transmitted from one person to another either directly or indirectly. These diseases can be divided into three categories - diseases that cause high levels of mortality, diseases that inflict a large load of disability on populations, and diseases that - due to their rapid and unexpected spread - can have serious global consequences. Many of the significant health factors and infectious disease causes are beyond the health sector's direct control.
The rising prevalence of infectious diseases such as COVID-19, influenza, the common cold, tuberculosis (TB), hepatitis A and B is expected to flourish the demand for plant-based vaccines during the forecast period. On December 31, 2019, a COVID-19 case was first detected in Wuhan, China. On March 11, 2020, the World Health Organization proclaimed COVID-19 a pandemic. COVID-19's rapid proliferation is posing a challenge to the healthcare systems around the world. Hospitals and intensive care units (ICUs) in many nations are overburdened or on the verge of collapsing. As a result, the most efficient use of healthcare resources is required. With limited access to breathing equipment, skilled critical care employees, or protected patient monitoring systems, healthcare providers are compelled to treat extremely ill patients. The endeavor to keep COVID-19 patients from deteriorating and being admitted to the ICU is enormous. To slow the spread of the SARS-CoV-2 virus and prevent future outbreaks, the need for new diagnostics, treatments, and vaccinations is high.
Malaria is the most common tropical human disease caused by protozoan parasites, with an increasing incidence and mortality rate. Furthermore, there are currently no licensed vaccinations for this disease, fueling the need to develop an effective and reliable anti-malaria vaccine that can protect humans from various parasitic infection stages containing various malaria antigens. For example, according to the WHO figures from July 2018, there were 216 million malaria cases worldwide in 2016, with 445,000 deaths reported. The worldwide plant-based vaccine market is expected to rise due to rising influenza incidence rates. According to the Centers for Disease Control and Prevention (CDC), in the US, influenza caused 49,000,000 symptomatic illnesses and 79,000 fatalities in 2017-2018. Hence, the rising number of infectious diseases worldwide is anticipated to boost the growth of the plant-based vaccines market during the forecast period.
Based on application, the global plant-based vaccines market is segmented into influenza, zika virus, Ebola virus, poultry disease, COVID-19, and others. The influenza segment held the largest share of the market. However, the COVID-19 segment is anticipated to register the highest CAGR of 13.8% in the market during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the plant-based vaccines market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the National Center for Biotechnology Information (NCBI).Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the plant-based vaccines market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global plant-based vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Plant-based Vaccines Market - By Vaccine Type
1.3.2 Global Plant-based Vaccines Market - By Source
1.3.3 Global Plant-based Vaccines Market - By Application
1.3.4 Global Plant-based Vaccines Market - By Geography
2. Global Plant-based Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Plant-based Vaccines Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Experts Opinion
5. Plant-based Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Research & Development (R&D) Activities in Plant-Based Vaccines
5.1.2 Growing Prevalence of Infectious Diseases
5.2 Market Restraints
5.2.1 Potential Risk of Contamination and Environmental Risks for Manufacturing Plant-Based Vaccines
5.3 Market Opportunities
5.3.1 Advancements in Production of Plant-Based Vaccines
5.4 Future Trends
5.4.1 Spur in Prevalence of Infectious Diseases and Increase in Product Approvals
5.5 Impact Analysis
6. Plant-based Vaccines Market- Global Analysis
6.1 Global Plant-based Vaccines Market Revenue Forecast and Analysis
6.2 Global Plant-based Vaccines Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Plant-Based Vaccines Market Analysis - By Vaccine Type
7.1 Overview
7.2 Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
7.3 Bacterial Vaccines
7.3.1 Overview
7.3.2 Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Viral Vaccines
7.4.1 Overview
7.4.2 Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Parasite Vaccines
7.5.1 Overview
7.5.2 Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Plant-derived Virus-like Particles (VLPs)
7.6.1 Overview
7.6.2 Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
8. Plant-based Vaccines Market Analysis - By Source
8.1 Overview
8.2 Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
8.3 Tobacco Plant
8.3.1 Overview
8.3.2 Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Maize
8.4.1 Overview
8.4.2 Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Potato
8.5.1 Overview
8.5.2 Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9. Plant-based Vaccines Market Analysis- by Application
9.1 Overview
9.2 Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
9.3 Influenza
9.3.1 Overview
9.3.2 Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Zika Virus
9.4.1 Overview
9.4.2 Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Ebola Virus
9.5.1 Overview
9.5.2 Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Poultry Disease
9.6.1 Overview
9.6.2 Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Covid-19
9.7.1 Overview
9.7.2 Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10. Plant-based Vaccines Market - Geographic Analysis
10.1 North America: Plant based vaccines Market
10.1.1 Overview
10.1.2 North America Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America Plant-Based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.1.4 North America Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.5 North America Plant-Based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.6 North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 US: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.2 US Plant-Based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.4 US Plant-Based Vaccines Market, by Application- Revenue and Forecast to 2028 (US$ Million)
10.1.6.2 Canada: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Canada: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.2 Canada Plant-Based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada Plant-Based Vaccines Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.4 Canada Plant-Based Vaccines Market, by Application- Revenue and Forecast to 2028 (US$ Million)
10.1.6.3 Mexico: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Mexico: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.2 Mexico Plant-Based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.4 Mexico Plant-Based Vaccines Market, by Application- Revenue and Forecast to 2028 (US$ Million)
10.2 Europe: Plant-based Vaccines Market
10.2.1 Overview
10.2.2 Europe: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Plant-based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Germany: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.2 Germany: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 Germany: Plant-based Vaccines Market, By Application- Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 France: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.2 France: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 France: Plant-based Vaccines Market, By Application- Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 UK: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.2 UK: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 UK: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 UK: Plant-based Vaccines Market, By Application- Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Italy: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.2 Italy: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4 Italy: Plant-based Vaccines Market, By Application- Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Spain: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.2 Spain: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Spain: Plant-based Vaccines Market, By Application- Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Rest of Europe: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.2 Rest of Europe: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Plant-based Vaccines Market, By Application- Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific: Plant-based Vaccines Market
10.3.1 Overview
10.3.2 Asia Pacific: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.3.4 Asia Pacific: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.5 Asia Pacific: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6 Asia Pacific: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 China: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.2 China: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.4 China: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2 Japan: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Japan: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.2 Japan: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.4 Japan: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3 India: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.1 India: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.2 India: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.4 India: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4 South Korea: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 South Korea: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.2 South Korea: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.4 South Korea: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5 Australia: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Australia: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.2 Australia: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.4 Australia: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Rest of Asia Pacific: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.2 Rest of Asia Pacific: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.4 South and Central America: Plant-Based Vaccines Market
10.4.1 Overview
10.4.2 South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 South and Central America Plant-Based Vaccines Market, By vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.4.4 South and Central America Plant-Based Vaccines Market, By Source - Revenue and Forecast to 2028 (US$ Million)
10.4.5 South and Central America Plant-Based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6 South and Central America: Plant-Based Vaccines Market Share by Country - 2021 & 2028, (%)
10.4.6.1 Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (US$ Million)
10.4.6.1.1 Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (US$ Million)
10.4.6.1.2 Brazil Plant-Based Vaccines Market, By Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Brazil Plant-Based Vaccines Market, By Source - Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.4 Brazil Plant-Based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2 Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (US$ Million)
10.4.6.2.1 Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (US$ Million)
10.4.6.2.2 Argentina Plant-Based Vaccines Market, By Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Argentina Plant-Based Vaccines Market, By Source - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.4 Argentina Plant-Based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3 Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.2 Rest of South and Central America Plant-Based Vaccines Market, By Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 Rest of South and Central America Plant-Based Vaccines Market, By Source - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.4 Rest of South and Central America Plant-Based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
10.5 Middle East & Africa: Plant-based Vaccines Market
10.5.1 Middle East & Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
10.5.2 Middle East & Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.5.3 Middle East & Africa: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.5.4 Middle East & Africa: Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.5.5 Middle East & Africa: Plant-based Vaccines Market, by Country, 2021& 2028 (%)
10.5.5.1 Saudi Arabia: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
10.5.5.1.1 Saudi Arabia: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
10.5.5.1.2 Saudi Arabia: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.5.5.1.3 Saudi Arabia: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.5.5.1.4 Saudi Arabia: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (US$ Million)
10.5.5.2 South Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
10.5.5.2.1 South Africa: Plant-based Vaccines Market Market- Revenue and Forecast to 2028 (US$ Million)
10.5.5.2.2 South Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.5.5.2.3 South Africa : Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.5.5.2.4 South Africa: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (US$ Million)
10.5.5.3 UAE: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
10.5.5.3.1 UAE: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
10.5.5.3.2 UAE: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.5.5.3.3 UAE: Plant-based Vaccines Market, by Source- Revenue and Forecast to 2028 (US$ Million)
10.5.5.3.4 UAE: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (US$ Million)
10.5.5.4 Rest of Middle East & Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
10.5.5.4.1 Rest of Middle East & Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
10.5.5.4.2 Rest of Middle East & Africa: Plant-based Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
10.5.5.4.3 Rest of Middle East & Africa: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.5.5.4.4 Rest of Middle East & Africa: Plant-based Vaccines Market, by Application- Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic On Global Plant-based Vaccines Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Plant-based Vaccines Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Plant-based Vaccines Market, 2019-2021
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MEDICAGO, INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 British American Tobacco p.l.c.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ICON GENETICS GMBH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
SWOT Analysis
13.3.5 Key Developments
13.4 CREATIVE BIOLABS, INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 iBio, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 LENIOBIO
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Lumen Bioscience, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 LEAF EXPRESSION SYSTEMS LTD.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ZYUS LIFE SCIENCES INC.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 FRAUNHOFER CMB
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Publisher
14.2 Glossary of Terms
List of Tables
Table 1. North America Plant-Based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Plant-Based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Plant-Based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Plant-Based Vaccines Devices Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Plant-Based Vaccines Devices Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Plant-Based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Plant-based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Plant-based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million).
Table 19. France: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. France: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 21. France: Plant-based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million).
Table 22. UK: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Plant-based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million).
Table 25. Italy: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Plant-based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million).
Table 28. Spain: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Plant-based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million).
Table 31. Rest of Europe: Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Plant-based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million).
Table 34. Asia Pacific Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 37. China Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 38. China Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 39. China Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 43. India Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 44. India Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 45. India Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 55. South and Central America Plant-Based Vaccines Market, By vaccine Type- Revenue and Forecast to 2028 (US$ Million)
Table 56. South and Central America Plant-Based Vaccines Market, By Source - Revenue and Forecast to 2028 (US$ Million)
Table 57. South and Central America Plant-Based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 58. Brazil Plant-Based Vaccines Market, By Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
Table 59. Brazil Plant-Based Vaccines Market, By Source - Revenue and Forecast to 2028 (US$ Million)
Table 60. Brazil Plant-Based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 61. Argentina Plant-Based Vaccines Market, By Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
Table 62. Argentina Plant-Based Vaccines Market, By Source - Revenue and Forecast to 2028 (US$ Million)
Table 63. Argentina Plant-Based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of South and Central America Plant-Based Vaccines Market, By Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of South and Central America Plant-Based Vaccines Market, By Source - Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of South and Central America Plant-Based Vaccines Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 67. Middle East & Africa Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 68. Middle East & Africa Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 69. Middle East & Africa Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 70. Saudi Arabia Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 71. Saudi Arabia Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 72. Saudi Arabia Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 73. South Africa Apnea Diagnostics Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 74. South Africa Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 75. South Africa Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 76. UAE Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 77. UAE Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 78. UAE Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of Middle East & Africa Plant-based Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of Middle East & Africa Plant-based Vaccines Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of Middle East & Africa Plant-based Vaccines Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 82. Recent organic developments in the Plant-based Vaccines Market
Table 83. Glossary of Terms, plant-based vaccines devices marketList of Figures
Figure 1. Plant-based Vaccines Market Segmentation
Figure 2. Plant-based Vaccines Market Segmentation, By Region
Figure 3. Global Plant-based Vaccines Market Overview
Figure 4. Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in Plant-based Vaccines Market
Figure 5. Asia Pacific to Show Significant Growth during Forecast Period
Figure 6. Plant-based Vaccines Market, by Geography (US$ Million)
Figure 7. Global Plant-based Vaccines Market - Leading Country Markets (US$ Million)
Figure 8. Global Plant-based Vaccines Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Plant-Based Vaccines Market Impact Analysis of Driver and Restraints
Figure 15. Global Plant-based Vaccines Market- Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Plant-based Vaccines Market - By Geography Forecast and Analysis - 2021- 2028
Figure 17. Market Positioning of Key Players in Global Plant-based Vaccines Market
Figure 18. Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
Figure 19. Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
Figure 25. Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 30. Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America: Plant-Based Vaccines Market, by Key Country - Revenue (2021) (US$ Million)
Figure 37. North America Plant-Based Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 39. US: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Canada: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Mexico: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Europe: Plant-based Vaccines Market, by Key Country - Revenue (2021) (US$ Million)
Figure 43. Europe: Plant-based Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 45. Germany: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. France: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. UK: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Italy: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Spain: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Rest of Europe: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Asia Pacific: Plant-based Vaccines Market, by Key Country - Revenue (2021) (US$ Million)
Figure 52. Asia Pacific Plant-based Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 54. China Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Japan: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. India: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. South Korea: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. Australia: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Asia Pacific: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. South and Central America: Plant-Based Vaccines Market, By Key Country - Revenue (2021) (US$ Million)
Figure 61. South and Central America: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (US$ Million)
Figure 62. South and Central America: Plant-Based Vaccines Market Share by Country - 2021 & 2028, (%)
Figure 63. Brazil: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (US$ Million)
Figure 64. Argentina: Plant-Based Vaccines Market- Revenue and Forecasts To 2028 (US$ Million)
Figure 65. Rest of South and Central America: Plant-Based Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. Middle East & Africa: Plant-based Vaccines Market, by Key Country - Revenue (2021) (US$ Million)
Figure 67. Middle East & Africa Plant-based Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 68. Middle East & Africa: Plant-based Vaccines Market, by Country, 2021& 2028 (%)
Figure 69. Saudi Arabia: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
Figure 70. South Africa: Plant-based Vaccines Market Market- Revenue and Forecast to 2028 (US$ Million)
Figure 71. UAE: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
Figure 72. Rest of Middle East & Africa: Plant-based Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
Figure 74. Impact of COVID-19 Pandemic In European Country Markets
Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 76. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 77. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 78. Growth Strategies in the Plant-based Vaccines Market, 2019-2021
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- MEDICAGO, INC.
- British American Tobacco p.l.c.
- ICON GENETICS GMBH
- CREATIVE BIOLABS, INC.
- iBio, Inc.
- LENIOBIO
- Lumen Bioscience, Inc.
- LEAF EXPRESSION SYSTEMS LTD.
- ZYUS LIFE SCIENCES INC.
- FRAUNHOFER CMB
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 243 |
| Published | November 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 1143.72 Million |
| Forecasted Market Value ( USD | $ 2672.05 Million |
| Compound Annual Growth Rate | 12.9% |
| Regions Covered | Global |
